Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma

Multiple myeloma (MM) is a devastating plasma cell malignancy characterized by the expansion of aberrant monoclonal plasma cells in the bone marrow, leading to severe clinical manifestations and poor prognosis, particularly in relapsed/refractory cases. Identifying novel therapeutic targets is cruci...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hong Phuong, Le, Anh Quynh, Liu, Enze, Cesarano, Annamaria, DiMeo, Francesco, Perna, Fabiana, Kapur, Reuben, Walker, Brian A., Tran, Ngoc Tung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436492/
https://www.ncbi.nlm.nih.gov/pubmed/37600810
http://dx.doi.org/10.3389/fimmu.2023.1239614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436492/
https://www.ncbi.nlm.nih.gov/pubmed/37600810
http://dx.doi.org/10.3389/fimmu.2023.1239614

Ejemplares similares